4//SEC Filing
Elting Kimberley A. 4
Accession 0001209191-23-002664
CIK 0000884624other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 7:12 PM ET
Size
13.6 KB
Accession
0001209191-23-002664
Insider Transaction Report
Form 4
Elting Kimberley A.
Chief Legal Officer
Transactions
- Award
Common Stock
2023-01-05+35,129→ 140,924 total - Award
Common Stock
2023-01-05+12,229→ 164,687 total - Award
Employee Stock Option (Right to Buy)
2023-01-05+84,566→ 84,566 totalExercise: $20.90Exp: 2033-01-05→ Common Stock (84,566 underlying) - Award
Common Stock
2023-01-05+11,534→ 152,458 total - Award
Common Stock
2023-01-05+20,492→ 185,179 total
Footnotes (5)
- [F1]The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.
- [F2]Represents outstanding performance stock units for awards granted in 2020, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on June 8, 2023.
- [F3]Represents outstanding performance stock units for awards granted in 2021, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on April 1, 2024.
- [F4]Represents outstanding performance stock units for awards granted in 2022, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on January 31, 2025.
- [F5]The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.
Documents
Issuer
Orthofix Medical Inc.
CIK 0000884624
Entity typeother
Related Parties
1- filerCIK 0001605209
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 7:12 PM ET
- Size
- 13.6 KB